New patent expiration for Novartis drug STARLIX

Annual Drug Patent Expirations for STARLIX Starlix is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are four patents protecting…
The post New patent expiration for Novartis drug STARLIX appeared …


New tentative approval for Watson Labs drug dienogest; estradiol valerate

Dienogest; estradiol valerate is the generic ingredient in one branded drug marketed by Bayer Hlthcare and is included in one NDA. There are four patents protecting this compound. This ingredient…
The post New tentative approval for Watson Labs d…


Should Price or Product Be the Determinant in Pharmaceutical Competition?

Pharmaceutical competition incorporates different tactics in different markets because countries have divergent approaches to regulating healthcare costs. Both price and product have roles in defining the competitive landscape in pharmaceuticals,&#8230…


Drug Patent Expirations for the Week of November 12, 2017

INVEGA SUSTENNA (paliperidone palmitate) Janssen pharms Patent: 6,077,843 Expiration: Nov 12, 2017 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug …


New patent expiration for Sankyo drug PRELAY

Annual Drug Patent Expirations for PRELAY Prelay is a drug marketed by Sankyo and is included in one NDA. There are two patents protecting this drug. This drug has forty-five…
The post New patent expiration for Sankyo drug PRELAY appeared first o…


Which pharmaceutical companies have the most suspension dosed drugs?

This chart shows the pharmaceutical companies with the most suspension dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most suspension dosed drugs…
The post Which pharmaceutical companies have t…


New tentative approval for Watson Labs drug dienogest; estradiol valerate

Dienogest; estradiol valerate is the generic ingredient in one branded drug marketed by Bayer Hlthcare and is included in one NDA. There are four patents protecting this compound. This ingredient…
The post New tentative approval for Watson Labs d…


New patent expiration for Janssen Pharms drug INVEGA TRINZA

Annual Drug Patent Expirations for INVEGA+TRINZA Invega Trinza is a drug marketed by Janssen Pharms and is included in one NDA. It is available from one supplier. There is one…
The post New patent expiration for Janssen Pharms drug INVEGA TRINZA …


Drug Patent Expirations for the Week of November 12, 2017

INVEGA SUSTENNA (paliperidone palmitate) Janssen pharms Patent: 6,077,843 Expiration: Nov 12, 2017 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug …


Do NOT follow this link or you will be banned from the site!
%d bloggers like this: